Literature DB >> 17160990

Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome.

Renu Pandit1, Aaron Scholnik, Louis Wulfekuhler, Nikolay Dimitrov.   

Abstract

Eosinophilia associated with solid tumors is an infrequent occurrence. The pathogenesis of tumor-associated eosinophilia is not well understood. Interleukin-5 (IL-5) is a cytokine that has been implicated in the development of eosinophilia in mice and humans. However, there is little data associating IL-5 production with eosinophilia in the presence of tumor. We report, in a patient with locally advanced NSCLC, the presence of excessive eosinophilia and elevated serum IL-5 levels at diagnosis. Immunohistochemical staining of the primary tumor showed large amounts of intracellular IL-5. Both eosinophil count and IL-5 levels normalized after surgical removal of the tumor. Tumor-associated eosinophilia observed in this case is mediated by IL-5. The production of IL-5 is related to the presence of the tumor. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17160990     DOI: 10.1002/ajh.20789

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  21 in total

1.  Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer.

Authors:  Hiroki Kato; Katsura Kohata; Joji Yamamoto; Satoshi Ichikawa; Mika Watanabe; Kenichi Ishizawa; Ryo Ichinohasama; Hideo Harigae
Journal:  Int J Hematol       Date:  2010-02-05       Impact factor: 2.490

2.  GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation.

Authors:  Colleen S Curran; Michael D Evans; Paul J Bertics
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 3.  Paraneoplastic syndromes associated with lung cancer.

Authors:  Nobuhiro Kanaji; Naoki Watanabe; Nobuyuki Kita; Shuji Bandoh; Akira Tadokoro; Tomoya Ishii; Hiroaki Dobashi; Takuya Matsunaga
Journal:  World J Clin Oncol       Date:  2014-08-10

Review 4.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

5.  Interleukin-5 facilitates lung metastasis by modulating the immune microenvironment.

Authors:  Rinat Zaynagetdinov; Taylor P Sherrill; Linda A Gleaves; Allyson G McLoed; Jamie A Saxon; Arun C Habermann; Linda Connelly; Daniel Dulek; R Stokes Peebles; Barbara Fingleton; Fiona E Yull; Georgios T Stathopoulos; Timothy S Blackwell
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

Review 6.  Eosinophilia in Hematologic Disorders.

Authors:  Lorenzo Falchi; Srdan Verstovsek
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

7.  Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia.

Authors:  Omar Abughanimeh; Mohammad Tahboub; Mouhanna Abu Ghanimeh
Journal:  Cureus       Date:  2018-06-22

Review 8.  The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.

Authors:  Stephanie S Eng; Magee L DeFelice
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

9.  Leucocytosis and Stroke in a Lung Cancer Patient.

Authors:  Neha Akkad; Yang Jiang; Daniel Shin
Journal:  Eur J Case Rep Intern Med       Date:  2020-08-14

10.  Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy.

Authors:  Adelaide Alves; Margarida Dias; Sérgio Campainha; Ana Barroso
Journal:  J Thorac Dis       Date:  2021-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.